ESC 365 - Impact of atorvastatin on serum oestradiol and estrone concentrations in postmenopausal women with chronic coronary artery disease: a randomized trial.

ESC Professional Premium Access

Impact of atorvastatin on serum oestradiol and estrone concentrations in postmenopausal women with chronic coronary artery disease: a randomized trial.

Session: Cardiovascular disease in women around the world

Topic: Cardiovascular Disease in Women

Speaker: Miss N. Faria (Sao Paulo, BR)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Miss Nathalia Faria

Heart Institute (InCor) HCFMUSP, Sao Paulo (Brazil)

0 follower

7 more presentations in this session

Sex differences in health status trajectories among Chinese patients with angina pectoris: insights from the GREAT registry study

Speaker: Professor X. Du (Beijing, CN)

Sex disparities in ischaemic heart disease mortality in South Asia: a global burden of disease 2021 analysis

Speaker: Ms T. Rahaman (Bologna, IT)

Coronary artery disease-related sudden cardiac arrest in women

Speaker: Doctor O. Weizman (Paris, FR)

Empagliflozin significantly reduces circulating markers of endothelial dysfunction in Ischemia with Non-Obstructive Coronary Arteries (INOCA) and coronary microvascular dysfunction: a pilot trial

Speaker: Doctor O. Quesada (Cincinnati, US)

Bridging the gender gap in TAVI: real-world evidence from a single-centre study

Speaker: Doctor R. Batista Louro (Evora, PT)

Access the full session

Cardiovascular disease in women around the world

Speakers: Miss N. Faria, Professor X. Du, Ms T. Rahaman, Doctor O. Weizman, Doctor O. Quesada...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources